QMSR Gap Analysis
Best for: Manufacturers selling, or planning to sell, in the US.
You receive
- QMSR gap report
- Prioritized action plan
- Debrief with your team
ISO 13485, EU MDR, US FDA QMSR and Gulf SFDA readiness for medical device and component manufacturers. Independent internal audits, clear scope, fixed-price packages.
Each market has its own rules, but they now share one foundation. Start with the market that matters most to you.
FDA · QMSR, 21 CFR Part 820
Explore Priority marketRegulation (EU) 2017/745 · notified bodies
Explore Priority marketTİTCK · Medical Device Regulation aligned with EU MDR
Explore Phase 2Saudi FDA · Medical Device Marketing Authorization
ExploreInternal audit reports, supplier audit reports and management reviews are now open to FDA inspection. Audits written for a drawer now need to stand up to an investigator.
Read more EU · MDRExtended MDD transition periods end on Dec 31, 2027 (Class III and IIb implantable) and Dec 31, 2028 (other devices). Notified body time is the bottleneck, not the legal date.
Read moreIndependent, risk-based internal audits against ISO 13485, the QMSR and the EU MDR, run remotely with secure screen sharing, and reported in a way that shows a working system.
Every service builds on the same ISO 13485 foundation, so work done for one market counts in the others.
Check your ISO 13485 system against the FDA QMSR and related US requirements, with a prioritized action plan.
DetailsOne QMS built to serve EU MDR, FDA QMSR, Türkiye and Gulf requirements: set-up, upgrade and training.
DetailsMDR transition, technical documentation, GSPR, ISO 14971 risk management and notified body preparation.
DetailsOn-site supplier audits for US and EU manufacturers sourcing components or services from Türkiye and Europe.
DetailsSterilization validation, test method validation, cleanroom and process validation reviews.
DetailsCAPA, nonconformance, complaints, document control, batch record review and product release.
DetailsBest for: Manufacturers selling, or planning to sell, in the US.
Best for: Manufacturers under ISO 13485, FDA QMSR or EU MDR who need an independent auditor.
Best for: Manufacturers selling in the EU who need to complete MDR certification.
A free 30-minute conversation about your device, target markets and current status.
A written assessment of where you stand against the requirements and what is missing.
Work packages, timeline and a fixed-scope proposal. No surprise hourly bills.
We do the work with your team, train them and hand the system over.
NDA before any document exchange, secure file sharing and defined retention.
No client document goes into an AI tool without your written consent. Final judgement is always human.
Checked before every engagement. We decline work where we cannot be independent.
Remote by default, on site in Türkiye and Europe.
The FDA Quality Management System Regulation incorporates ISO 13485:2016 and opens internal audit, supplier audit and management review reports to inspection. What changed and how to prepare.
CE / MDRHow are medical devices classified under MDR 2017/745 Annex VIII? The differences between Class I, IIa, IIb and III, a summary of all 22 rules and common mistakes.
CE / MDRThe MDR transition periods extended by Regulation 2023/607: which deadline applies to which device, the conditions for the extension and how to plan your transition.
Yes. We work remotely with US manufacturers and with non-US manufacturers selling into the US, mainly on internal audits, QMSR gap analyses and CAPA. We also audit suppliers in Türkiye and Europe on site for US companies.
We agree the agenda and evidence list in advance, then audit through video interviews and secure screen sharing of your eQMS or records. Processes that need physical observation are covered by a live video walkthrough or a short visit.
Not without your written consent. If you agree, we only use tools that do not train on customer data, and every conclusion is reviewed and signed off by a human expert.
Manufacturers of Class I to Class III devices and their component and service suppliers, with particular experience in implantable and sterile single-use devices. If we have a conflict of interest, we say so in the intro call.
No one can. Decisions are made by FDA and notified bodies. What we guarantee is a clear scope, honest assessment and deliverables that meet the agreed standard.
Tell us about your device, target markets and timeline. You’ll leave the call knowing which requirements apply, where your gaps likely are and what to do first.